⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDI News
Calidi Biotherapeutics, Inc.
Form 8-K
sec.gov
CLDI
CLDWW
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
globenewswire.com
CLDI
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
globenewswire.com
CLDI
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
globenewswire.com
CLDI
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDI
CLDWW
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
globenewswire.com
CLDI
LEGN
RARE
Form 8-K
sec.gov
CLDWW
CLDI